Company news
Angiodynamics, Inc. (NASDAQ:ANGO) news
Every Angiodynamics, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases — page 3
AngioDynamics to Present at the UBS Virtual Global Healthcare Conference
May 17, 2021
AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System
April 12, 2021
AngioDynamics Reports Fiscal 2021 Third Quarter Financial Results and Updates Guidance
March 30, 2021
AngioDynamics to Participate in a Virtual Fireside Chat at the KeyBanc Life Sciences & MedTech Investor Forum
March 15, 2021
AngioDynamics to Report Fiscal 2021 Third Quarter Financial Results on March 30, 2021
March 9, 2021
AngioDynamics to Participate in a Virtual Fireside Chat at the Oppenheimer Healthcare Conference
March 9, 2021
AngioDynamics to Present at the Barclays Virtual Global Healthcare Conference
March 1, 2021
AngioDynamics Appoints Richard C. Rosenzweig Senior Vice President, General Counsel and Secretary, Promotes Juan Carlos Serna to Senior Vice President, Scientific & Clinical Affairs
February 1, 2021
AngioDynamics Reports Fiscal 2021 Second Quarter Financial Results
January 7, 2021
AngioDynamics to Present at the J.P. Morgan Virtual Healthcare Conference
January 4, 2021
AngioDynamics to Report Fiscal 2021 Second Quarter Financial Results on January 7, 2021
December 9, 2020
AngioDynamics Announces Presentation of Positive Safety, Efficacy Results from RAPID Outcomes Database
November 12, 2020
AngioDynamics Reports Fiscal 2021 First Quarter Financial Results
September 29, 2020
AngioDynamics Announces Commercial Launch of Auryon Atherectomy System in United States
September 21, 2020
AngioDynamics to Report Fiscal 2021 First Quarter Financial Results on September 29, 2020
September 17, 2020
AngioDynamics Announces First Patient Enrolled in PATHFINDER I Registry Examining Long-Term Effectiveness and Safety of Auryon Atherectomy System
August 17, 2020
AngioDynamics to Participate in a Virtual Fireside Chat at the Canaccord Genuity Growth Conference
August 3, 2020
AngioDynamics Reports Fiscal 2020 Fourth Quarter and Full-Year Financial Results
July 16, 2020
AngioDynamics to Report Fiscal 2020 Fourth Quarter and Full-Year Financial Results on July 16, 2020
June 23, 2020
AngioDynamics to Participate in a Virtual Fireside Chat at the Raymond James Human Health Innovation Conference
June 8, 2020
AngioDynamics Reports Fiscal 2020 Third Quarter Financial Results
April 7, 2020
AngioDynamics to Report Fiscal 2020 Third Quarter Financial Results on April 7, 2020
March 10, 2020
AngioDynamics to Present at Two Investor Conferences in March
February 27, 2020
AngioDynamics Appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer
February 6, 2020
AngioDynamics Launches PATHFINDER I Registry to Evaluate Performance and Clinical Outcomes of the AURYON™ Atherectomy System
January 16, 2020
AngioDynamics Reports Fiscal 2020 Second Quarter Financial Results
January 7, 2020
AngioDynamics to Report Fiscal 2020 Second Quarter Financial Results on January 7, 2020
December 10, 2019
AngioDynamics Announces Departure of CFO and Appointment of Interim CFO
October 22, 2019
AngioDynamics Reports Fiscal 2020 First Quarter Financial Results
October 3, 2019
AngioDynamics Acquires Eximo Medical, Ltd. and its Innovative 355nm Laser Atherectomy Technology
October 3, 2019
AngioDynamics Awarded Premier’s Nationally Outsourced Implantable Infusion Port Agreement
September 9, 2019
AngioDynamics Announces Appointment of Former Johnson & Johnson Executive Karen Licitra to its Board of Directors
July 31, 2019
AngioDynamics’ DIRECT Clinical Study Receives Institutional Review Board Approval for the Treatment of Stage III Pancreatic Cancer
April 17, 2019
AngioDynamics Announces Agreement to Sell NAMIC® Fluid Management Business to Medline Industries, Inc. for $167.5 Million
April 17, 2019
AngioDynamics Reports Fiscal 2019 Third Quarter Financial Results
April 2, 2019